CDEK
← All organizations

Immutep S.A.

For profitWebsite ↗

Also known as: Immutep S.A. | Immutep S.A.S | Immutep S.A.S.

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Apr 1, 2005

Last known activity

Nov 1, 2025

Acquired by Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed → Immutep S.A. → Prima BioMed on Oct 2, 2014

Timeline

2000s

  1. Jun 1, 2001

    Immutep S.A.— Founded

2010s

  1. Oct 2, 2014

    Prima BioMed— Acquired By

  2. Oct 2, 2014

    Prima BioMed— Now

  3. Oct 2, 2014

    Prima BioMed— Acquired

Drugs by trial phase (16 distinct, 20 trials)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (23)

Details

Founded
Sydney, AU Jun 1, 2001
Last known activity
Nov 1, 2025